These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2811056)

  • 1. Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemia.
    Engerman RL; Kern TS
    Kidney Int; 1989 Jul; 36(1):41-5. PubMed ID: 2811056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney morphology in experimental hyperglycemia.
    Kern TS; Engerman RL
    Diabetes; 1987 Feb; 36(2):244-9. PubMed ID: 3803734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia as a cause of diabetic retinopathy.
    Engerman RL; Kern TS
    Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus.
    Phillips AO; Baboolal K; Riley S; Gröne H; Janssen U; Steadman R; Williams J; Floege J
    Am J Kidney Dis; 2001 Feb; 37(2):400-10. PubMed ID: 11157383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase and the development of renal disease in diabetic dogs.
    Kern TS; Engerman RL
    J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
    Engerman RL; Kern TS; Garment MB
    J Diabetes Complications; 1993; 7(4):241-5. PubMed ID: 8219367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamics in experimentally galactosemic dogs and diabetic dogs.
    Kern TS; Engerman RL
    Metabolism; 1991 May; 40(5):450-4. PubMed ID: 1902544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat.
    Donnelly SM; Zhou XP; Huang JT; Whiteside CI
    Biochem Cell Biol; 1996; 74(3):355-62. PubMed ID: 8883841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic glomerulopathy following unilateral nephrectomy in the dog.
    Whiteside C; Katz A; Cho C; Silverman M
    Clin Invest Med; 1990 Oct; 13(5):279-86. PubMed ID: 1703467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia.
    Engerman RL; Kern TS; Larson ME
    Metabolism; 1990 Jun; 39(6):638-40. PubMed ID: 2352480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients.
    Osterby R; Gall MA; Schmitz A; Nielsen FS; Nyberg G; Parving HH
    Diabetologia; 1993 Oct; 36(10):1064-70. PubMed ID: 8243856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M; Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 May; 37(5):454-60. PubMed ID: 3285132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrest of glomerulopathy in diabetic dogs by improved glycaemic control.
    Kern TS; Engerman RL
    Diabetologia; 1990 Sep; 33(9):522-5. PubMed ID: 2253827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy.
    Osterby R; Gundersen HJ
    Diabetologia; 1980 Jun; 18(6):493-500. PubMed ID: 7418958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of glomerular lesions in experimental long-term diabetes in the rat.
    Hirose K; Osterby R; Nozawa M; Gundersen HJ
    Kidney Int; 1982 May; 21(5):689-95. PubMed ID: 6981023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW; Mauer SM
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract]   [Full Text] [Related]  

  • 19. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention.
    Osterby R
    Diabetologia; 1992 Sep; 35(9):803-12. PubMed ID: 1397774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of diabetic nephropathy in animals and man.
    Mauer SM; Steffes MW; Michael AF; Brown DM
    Diabetes; 1976; 25(2 SUPPL):850-7. PubMed ID: 823065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.